Bortezomib Promising Treatment for Rheumatoid Arthritis

Links shared publicly online about this topic.

  • 752
    total visits

Bortezomib Promising Treatment for Rheumatoid Arthritis

disabled-world.com

Study suggests biologic drug bortezomib (Velcade) may represent a promising treatment for rheumatoid arthritis

View full resource at disabled-world.com

Tags: Arthritis, Rheumatoid Arthritis, Drug

  • Share

Most Recently Shared on November 4, 2010 at 1:39 pm By:

disabledworld Disabled World

Bortezomib Promising Treatment for Rheumatoid Arthritis http://ff.im/-t9rfq

2 years ago...

UAB - Arthritis drugs hold promise for multiple sclerosis

uab.edu — “A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to t...View full resource at uab.edu

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 7:39 pm By:

DerekDowell Derek Dowell Patient Expert

Arthritis drugs hold promise for multiple sclerosis http://t.co/TfM15Qci

3 months ago...

Is Rheumatoid Arthritis Prevention on the Horizon? - New Study Shows Promising Results

spineuniverse.com — “Researchers created a treatment to potentially prevent or reverse rheumatoid arthritis (RA) by imitating a molecule that causes attacking immune cells to self-destruct. The findings may help develop a new class of rheumatoid arthritis medications.View full resource at spineuniverse.com

  • View Related
  • Share

Most Recently Shared on July 14, 2011 at 11:27 pm By:

SpineUniverse SpineUniverse Health Site

Is Rheumatoid Arthritis Prevention on the Horizon? http://dlvr.it/bCjl0

10 months ago...

Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data Show Promise in the Treatment of Active Rheumatoid Arthritis - Health News - redOrbit

redorbit.com — “LONDON, May 25, 2011 /PRNewswire/ -- Results from a Phase 2 multicenter, randomized, double-blind, proof-of-concept and dose-finding study showed that treatment with sirukumab (CNTO 136) improved signs and symptoms of rheumatoid arthritis (RA) in patients with active disease despite treatment with methotrexate (MTX).View full resource at redorbit.com

  • View Related
  • Share

Most Recently Shared on May 25, 2011 at 4:03 pm By:

RA_Wisdom OrganizedWisdom RA OW Health

Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data Show Promise in the Treatment of Active Rheumatoid Art... http://bit.ly/mcrr2L

1 year ago...

Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data Show Promise In The Treatment Of Active Rheumatoid Arthritis

jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.View full resource at jnj.com

  • View Related
  • Share

Most Recently Shared on May 25, 2011 at 2:50 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data In The Treatment Of Active Rheumatoid Arthritis - http://ow.ly/52HWO

1 year ago...

The Future's So Bright: a Good Time to Have RA - Rheumatoid Arthritis

healthcentral.com — “I am in a large room in a downtown Toronto hotel, chairs lined up facing the front and around me are over 300 other people, most of whom are here for the same r...View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 4:14 pm By:

Health_Tips HealthCentral Tips Health Site

@TJFaustLV Here's the Latest Promising Treatments at least...The Future's So Bright: a Good Time to Have RA #Arthritis! http://bit.ly/khYpgS

1 year ago...

Conquering Arthritis - Arthritis Articles - Researching Promising Therapies Using PubMed

conqueringarthritis.com — “arthritis treatment, rheumatoid arthritis, rheumatoid arthritis treatment, Barbara Allan, Barbara Allen, conquering arthritis, researching therapies, verifying claims, pubmedView full resource at conqueringarthritis.com

  • View Related
  • Share

Most Recently Shared on April 4, 2011 at 2:52 pm By:

Arthritis drug could help beat melanoma skin cancer, study finds

sciencedaily.com — “A breakthrough discovery promises an effective new treatment for one of the deadliest forms of cancer. Researchers found that leflunomide -- a drug commonly used to treat rheumatoid arthritis -- also inhibits the growth of malignant melanoma.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on March 24, 2011 at 7:50 am By:

SkinCancer_OW Skin Cancer OW OW Health

Arthritis drug could help beat melanoma skin cancer, study finds: A breakthrough discovery promises an effective... http://bit.ly/i4selx

1 year ago...

Arthritis drug could help beat melanoma skin cancer, study finds

sciencedaily.com — “A breakthrough discovery promises an effective new treatment for one of the deadliest forms of cancer. Researchers found that leflunomide -- a drug commonly used to treat rheumatoid arthritis -- also inhibits the growth of malignant melanoma.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on March 24, 2011 at 12:10 am By:

sciencedaily sciencedaily Health News

Arthritis drug could help beat melanoma skin cancer, study finds: A breakthrough discovery promises an effective... http://bit.ly/gnLp5g

1 year ago...

Patent awarded for method to dampen immune response

eurekalert.org — “National Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating their antigen receptors. The method holds promise for treatment of B-cell mediated diseases, such as lymphoma, rheumatoid arthritis, lupus and rejection of organ transplants. Because this approach would inactivate B cells rather than kill them -- as current treatments do -- potential therapies could be more rapidly adjusted in response to the changing needs of patients.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on January 19, 2011 at 12:03 am By:

RA_Wisdom OrganizedWisdom RA OW Health

Patent awarded for method to dampen immune response: (National Jewish Health) National Jewish Health has been is... http://bit.ly/dR9lIP

1 year ago...

Study finds bortezomib to be promising treatment for rheumatoid arthritis

physorg.com — “A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on November 3, 2010 at 4:26 pm By:

FightCancer FightCancer Health News

Study finds bortezomib to be promising treatment for rheumatoid arthritis http://bit.ly/dld92C

2 years ago...

Proteasome inhibitor reduces inflammation and promotes bone healing in arthritis models

sciencedaily.com — “A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on November 3, 2010 at 1:12 pm By:

sciencedaily sciencedaily Health News

Proteasome inhibitor reduces inflammation and promotes bone healing in arthritis models: A new study by Greek rese... http://bit.ly/bzFruY

2 years ago...

New Treatment for Rheumatoid Arthritis | The Pain Center Of Arizona | Get Back Into Life

thepaincenter.com — “New Treatment for Rheumatoid Arthritis | The Pain Center Of Arizona | Get Back Into LifeView full resource at thepaincenter.com

  • View Related
  • Share

Most Recently Shared on September 29, 2010 at 4:31 pm By:

New vasculitis therapy: Researchers find new therapy for vasculitis - latimes.com

latimes.com — “Forty years after the development of the only therapy for vasculitis, a rare but severe disease of blood vessels, researchers have found a new therapy that is at least as effective, requires fewer treatments and promises far fewer side effects. Federally-funded researchers reported Wednesday that treatment with the biotech drug rituximab, already marketed as Rituxan for the treatment of B cell lymphoma and rheumatoid arthritis, is slightly more effective than the existing drug, cyclophosphamide,View full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on July 15, 2010 at 8:20 pm By:

drgaidhane Monica R.Gaidhane Doctor and Physician

New vasculitis therapy: Researchers find new therapy for vasculitis - latimes.com http://bit.ly/aHnDxU

2 years ago...

Rare Blood Vessel Disease Could Have New Treatment Option - Drugs.com MedNews

drugs.com — “A drug already used to treat lymphoma and rheumatoid arthritis shows promise as an option to treat rare forms of vasculitis, a disease affecting the blood vesseView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 14, 2010 at 10:18 pm By:

drugscom Drugs.com Health Site

Rare Blood Vessel Disease Could Have New Treatment Option - http://bit.ly/d6sT3c

2 years ago...

Advertisement